Expert Outlook Vikram Kasat of PL Capital Foresees RangeBound Market Favours BFSI Defence Pharma and Power Sectors Foreign Investors Offload Over Rs 30000 Crore in Indian Equities in May as 2026 Outflows Reach Rs 222 Lakh Crore AIs Potential in Accelerating Drug Discovery for Brain Conditions Like MND Three Companies Set to Launch New Public Offers This Week Amid Persistent Market Volatility Plus500 Reports 11 Quarterly Revenue Increase Reaffirms Market Expectations US Jobs Report Faces Another Delay Amid Ongoing Government Shutdown MLCO Q1 2026 Earnings EPS Surges Past Estimates with 81 Surprise RCI Hospitality Holdings Q3 2025 Earnings Deep EPS Miss Amidst Operating Headwinds CISS Q3 2025 Earnings Loss per Share of 058 Shares Decline 55 Ballard Power Systems BLDP Q1 2026 Earnings Narrowing Loss Beats Estimates Shares Edge Higher SHOO Q1 2026 Earnings EPS Surges Past Estimates by 1433 Contango ORE Inc CTGO Q1 2026 Earnings Significant EPS Miss Weighs on Shares Fox Corporation FOX Holds Near Resistance as Momentum Builds Teekay Corporation TK Edges Lower as Shares Consolidate Within Established Range Cohen Steers PTA Modest Decline as Preferred Securities Fund Hovers Near Midpoint ABVC BioPharma Surges 13 Key Levels and Potential Scenarios JinkoSolar JKS Slides 169 as Solar Sector Faces Headwinds Key Levels to Watch Market Expert Sunil Subramaniam Points to Q1 Earnings as Key Driver Amid Geopolitical and Cost Pressures Universal Display OLED Q1 2026 Earnings EPS Misses by a Wide Margin Stock Slips 1 Allspring Income Opportunities Fund EAD Edges Higher on Modest Gains AES Q1 2026 Earnings EPS Surges 80 Above Estimates Powered by Strong Execution CWBC Q1 2026 Earnings EPS Beats Estimates by 486 Stock Rises Modestly BKKT Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Revenue Uncertainty KULR Q3 2025 Earnings EPS Misses Estimates by Wide Margin Stock Rises 655 SLSN Q1 2026 Earnings Narrow Loss Reported Amid Quiet Quarter Thermon Group Holdings Q1 2026 Earnings Narrow EPS Miss Amid Positive Sentiment Akebia Therapeutics Inc AKBA Q1 2026 Earnings EPS Misses Estimates Slightly Stock Unchanged